In a recent review published in the journal Nature Reviews Microbiology, researchers systematically reviewed the impacts of various dietary components and complete dietary regimes on gut...
Patients who receive GLP-1 receptor agonist semaglutide (Ozempic; Novo Nordisk) may have an increased risk of developing nonarthritic anterior ischemic optic neuropathy (NAION), according to a...
In a recent study published in The Journal of Nutrition, researchers examined the effects of low- and high-glycemic-index (GI) Mediterranean-style (MED) healthy eating patterns (HEPs) on...
Credit: Adobe Stock/Valentina New research revealed socioeconomic factors, such as age and gender, and living in socially deprived areas were linked to persistently active rheumatoid arthritis...
There is a complex relationship between sodium intake and heart health outcomes in patients with cardiovascular disease, diabetes, and heart failure, according to recent research. One...
In a recent review published in the journal Frontiers Endocrinology, researchers collate and elucidate recent clinical and pathophysiological knowledge on Tirzepatide. This novel anti-obesity and weight...
In a recent study published in the journal Nutrition and Metabolism, researchers evaluated the causal effects of dried fruit intake on type 2 diabetes (T2D). Dried...
Results from a Mendelian randomization analysis suggest type 1 diabetes was associated with a significant increase in the likelihood of multiple autoimmune skin conditions, including rheumatoid...
ntil now, people have had to prick their fingers or use an expensive and rigid sensor to test their blood for glucose, urea and other indicators;...
Fenugreek, a herb commonly used in the kitchen, is known for its numerous health benefits, including blood sugar regulation. According to a study published in the...
A new paper has highlighted the significant impact of type 2 diabetes on pulmonary health, particularly pulmonary vascular dysfunction and fibrosis. According to the review published...
The combined use of sodium-glucose transport protein 2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists may offer notable benefits for optimizing cardiovascular and renal outcomes...